Thursday, March 13, 2025 3/13/2025

Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models

Award Number: R01NS113803
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Group Awards By:

View Award Abstract

PROJECT SUMMARY In 2017 an MRI was performed at a rate of over one for every 10 US residents. The majority of these were brain MRIs. Indeterminate mass lesions are present on over 1% of brain MRIs in individuals over 45 years old. Misinterpretation of brain MRI can lead to significant iatrogenic morbidity and mortality. For example, tumefactive Central Nervous System Inflammatory Demyelinating Disease (CNSIDD) is commonly misdiagnosed as a malignancy, even following pathological review. This results in inappropriate brain biopsies, debulking and radiation. While early tumor resection is associated with favorable outcome in patients with high- grade glioma, observation, biopsy at an alternate site or nonsurgical options are often more appropriate for other indeterminate mass lesions that can encompass low-grade primary brain tumor, CNSIDD, CNS lymphoma and brain metastasis. Thus, to prevent iatrogenic morbidity, there is a critical need for scalable and reproducible methods to distinguish CNSIDD from other brain lesions, and to accurately diagnose brain tumors prior to biopsy. We recently published a polygenic risk model demonstrating that the 25 known glioma germline risk variants can estimate absolute and lifetime glioma risk. The clinical significance of these models is driven by germline variants that are associated with >4-fold increased risk of glioma. We have also shown that the same 25 germline variants can predict glioma molecular subtype. As a complementary approach, we have shown that imaging characteristics differ across glioma, CNSIDD, CNS lymphoma and brain metastases. We have successfully utilized MRI-based machine learning to predict the molecular subtype in high-grade glioma. We hypothesize that both germline genotyping and MRI-based machine learning provide an opportunity to diagnose indeterminate mass lesions as well as predict glioma molecular subtype prior to surgery and thus personalized treatment. The project has the following three aims: Aim 1: Develop and validate a MRI-based machine learning model to differentiate adult diffuse glioma from tumefactive CNSIDD, CNS lymphoma and solitary brain metastases of unknown primary. Aim 2: Evaluate sensitivity and specificity of the polygenic glioma risk model to differentiate adult diffuse glioma from tumefactive CNSIDD, CNS lymphoma and solitary brain metastases. Aim 3: Integrate the polygenic glioma subtype model and MRI-based machine learning model to predict adult diffuse glioma molecular subtype and validate the integrated model using a prospective cohort. The proposed project will further enhance the care of patients by determining if an early MRI lesion is actually a glioma. Early definitive surgery in these patients could be curative.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $604,387 )
2024	2024	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	5	5/29/2024	NON-COMPETING CONTINUATION	$604,387
														Subtotal = $604,387

Issue Date FY: 2023 ( Subtotal = $623,080 )
2023	2023	MAYO CLINIC	200 1ST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	4	5/25/2023	NON-COMPETING CONTINUATION	$623,080
														Subtotal = $623,080

Issue Date FY: 2022 ( Subtotal = $623,080 )
2022	2022	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	6/27/2022	NON-COMPETING CONTINUATION	$623,080
														Subtotal = $623,080

Issue Date FY: 2021 ( Subtotal = $623,080 )
2021	2021	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	5/17/2021	NON-COMPETING CONTINUATION	$623,080
														Subtotal = $623,080

Issue Date FY: 2020 ( Subtotal = $623,080 )
2020	2020	MAYO CLINIC	200 FIRST ST SW	ROCHESTER	MN	55905	OLMSTED	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	1	7/28/2020	NEW	$623,080
														Subtotal = $623,080

Grand Total All Awards = $3,096,707

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Diagnosis of indeterminate brain lesions using MRI-based machine learning and polygenic risk models

Award Number: R01NS113803

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer